These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25555143)

  • 1. Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.
    Canale V; Kurczab R; Partyka A; Satała G; Witek J; Jastrzębska-Więsek M; Pawłowski M; Bojarski AJ; Wesołowska A; Zajdel P
    Eur J Med Chem; 2015 Mar; 92():202-11. PubMed ID: 25555143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
    Canale V; Guzik P; Kurczab R; Verdie P; Satała G; Kubica B; Pawłowski M; Martinez J; Subra G; Bojarski AJ; Zajdel P
    Eur J Med Chem; 2014 May; 78():10-22. PubMed ID: 24675176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the halogen bonding on D
    Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
    Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
    Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
    Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
    Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
    Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.
    Kim Y; Tae J; Lee K; Rhim H; Choo IH; Cho H; Park WK; Keum G; Choo H
    Bioorg Med Chem; 2014 Sep; 22(17):4587-96. PubMed ID: 25127461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT
    Gu ZS; Xiao Y; Zhang QW; Li JQ
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5420-5423. PubMed ID: 29138029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.
    Modica MN; Intagliata S; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1427-30. PubMed ID: 25759032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity.
    Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G
    J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT(1A) receptor and serotonin transporter affinity.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Siwek A; Bojarski AJ; Bednarski M; Wróbel D; Wesołowska A
    Arch Pharm (Weinheim); 2013 Feb; 346(2):98-109. PubMed ID: 23288448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.
    Zagórska A; Bucki A; Kołaczkowski M; Siwek A; Głuch-Lutwin M; Starowicz G; Kazek G; Partyka A; Wesołowska A; Słoczyńska K; Pękala E; Pawłowski M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):10-24. PubMed ID: 27353547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new class of 5-HT
    Jankowska A; Satała G; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Głuch-Lutwin M; Bojarski AJ; Wyska E; Chłoń-Rzepa G
    Future Med Chem; 2021 Sep; 13(18):1497-1514. PubMed ID: 34253032
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2006 Mar; 14(5):1391-402. PubMed ID: 16266808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT₁A receptor functional profile.
    Partyka A; Chłoń-Rzepa G; Wasik A; Jastrzębska-Więsek M; Bucki A; Kołaczkowski M; Satała G; Bojarski AJ; Wesołowska A
    Bioorg Med Chem; 2015 Jan; 23(1):212-21. PubMed ID: 25435254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary pharmacological evaluation of imidazo[2,1-f]purine-2,4-dione derivatives.
    Zagórska A; Jurczyk S; Pawłowski M; Dybała M; Nowak G; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E
    Eur J Med Chem; 2009 Nov; 44(11):4288-96. PubMed ID: 19679379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.